drugset

drugset / Trial / NCT04333004

Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy

NCT04333004 ↗

Phase 1/2 Unknown 40 enrolled Xiaorong Dong

NaSingle-groupOpen-labelTreatment

Summary

Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy

Timeline

Start: 2020-04
Primary completion: 2021-04
Completion: 2022-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Pembrolizumab	Monoclonal antibody	—	—

Indications